Adagio Therapeutics, Inc. (16)

Browse by Contract Category

Contracts

Form of Amended and Restated Employment Agreement to be entered into by and between the Registrant and Lynn Connolly (Filed With SEC on August 4, 2021)
Form of Underwriting Agreement (Filed With SEC on August 2, 2021)
Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on August 2, 2021)
Assignment and License Agreement by and between the Registrant and Adimab, LLC, dated July 8, 2020 (Filed With SEC on July 16, 2021)
Form of Employment Agreement to be entered into by and between the Registrant and Tillman U. Gerngross (Filed With SEC on August 4, 2021)
Form of Employment Agreement to be entered into by and between the Registrant and Rebecca Dabora (Filed With SEC on August 4, 2021)
2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Notice of Exercise, RSU Award Grant Notice and RSU Award Agreement (Filed With SEC on August 2, 2021)
2021 Employee Stock Purchase Plan (Filed With SEC on August 2, 2021)
Form of Employment Agreement to be entered into by and between the Registrant and Tillman U. Gerngross (Filed With SEC on August 2, 2021)
Form of Amended and Restated Employment Agreement to be entered into by and between the Registrant and Lynn Connolly (Filed With SEC on August 2, 2021)
Form of Employment Agreement to be entered into by and between the Registrant and Rebecca Dabora (Filed With SEC on August 2, 2021)
Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated April 16, 2021 (Filed With SEC on July 16, 2021)
2020 Equity Incentive Plan and Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Exercise (Filed With SEC on July 16, 2021)
Collaboration Agreement by and between the Registrant and Adimab, LLC, dated May 21, 2021 (Filed With SEC on July 16, 2021)
Commercial Manufacturing Services Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated December 24, 2020 (Filed With SEC on July 16, 2021)
Cell Line License Agreement by and between the Registrant and WuXi Biologics (Hong Kong) Limited, dated December 2, 2020 (Filed With SEC on July 16, 2021)